| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-68 |
| filingDate |
1998-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0de31efff5b83b748b9a009fc96228ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed70aba4a5dc18552727935a769ecb56 |
| publicationDate |
1999-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H11130777-A |
| titleOfInvention |
Thienopyridine derivatives, intermediates thereof and methods for their production |
| abstract |
PROBLEM TO BE SOLVED: To provide a method capable of efficiently and safely producing a synthetic intermediate for producing a thienopyridine derivative useful as a GnRH antagonist at a high industrial scale in a high yield. SOLUTION: By subjecting an N-alkenyl-substituted 2-aminothiophen-3-carboxylic acid ester derivative to a ring-closing reaction, 5-acyl-4-hydroxythieno [2,3- b] The pyridine derivative can be produced in a short process with high yield. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7407966-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006041985-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7576211-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7488736-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006041985-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114894-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7598265-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7982040-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7612078-B2 |
| priorityDate |
1997-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |